Tornqvist, B., Stromberg, C., Persson, G
Small Animal Toxicology
2014), as well as patients with pathophysiological conditions, such as gyrate atrophy, post-stroke depression, congestive heart failure, chronic musculoskeletal pain disorders, atherosclerotic diseases, and cisplatin-induced renal damage (Genc et al
On the one hand, cell type-specific susceptibility manifests in multiple sclerosis (MS), where oligodendrocytes undergo ferroptosis via the IFN- -JAK1/STAT1 axis, reducing SLC7A11 expression that impairs cystine import for glutathione synthesis and leading to myelin basic protein (MBP) peroxidation as cell antioxidant capacity weakens due to decreased glutathione levels, the IFN--JAK1/STAT1 axis activation starts a cascade: IFN- binds to receptors, phosphorylating STAT1 through JAK1 activation, which then translocates to the nucleus to regulate ferroptosis-related genes (Lin and Lin, 2010)
This product is sold exclusively for laboratory, analytical, or scientific research and is not intended for human or veterinary use of any kind
BPC-157 is not approved for human use and is often sold as a research chemical or dietary supplement, which raises concerns about quality and safety